In our next issue, we explore how continuous and modular manufacturing, generative AI for process design, and emerging market production are reshaping global manufacturing - alongside the scalability challenges driving the future of GLP-1 therapies.
Next Issue
April 2026
EDITORIAL
Editor-in-Chief | Catherine Longworth
Deputy Editor |Ross Law
Writers | Robert Barrie, Annabel Kartal Allen, Abigail Beaney, Bernard Banga
Graphic Designers | Anett Arc, Noemi Balint
ADVERTISING
Account Managers:
Amman Khan +44 (0) 20 7866 9480
Liz Garbutt +44 (0) 20 7866 9441
Copyright 2026 NRi Digital, a trading division of Verdict Media Ltd. Registered office John Carpenter House, John Carpenter Street, London, EC4Y 0AN, UK. Company registration number 03171601. All rights reserved. No part of this publication may be reproduced in any form or by any means, electronic, photocopying or otherwise, without prior permission of the publisher and copyright owner. While every effort has been made to ensure the accuracy of this publication, the publisher accepts no responsibility for errors or omissions. The products and services advertised are those of individual authors and are not necessarily endorsed by or connected with the publisher. The opinions expressed in the articles within this publication are those of individual authors and not necessarily those of the publisher.